Argentina will receive some 22 million doses of AstraZeneca vaccines

Post available in: English

Argentina has struck a deal with drug maker AstraZeneca Plc to receive around 22 million doses of its COVID-19 vaccine being developed with the University of Oxford, with the aim to start deliveries in the first half of next year.

 The drug maker, one of a number developing vaccines worldwide to fight the novel coronavirus, said in a statement circulated by the government on Saturday that the delivery time-frame depended on ongoing trials being successful and obtaining necessary approvals by regulatory authorities.

Argentina, which is starting to see new cases slow, is hoping to receive some 10 million doses of Russia’s Sputnik V vaccine and a smaller number of doses of Pfizer Inc’s vaccine between December-January.

Argentina is among the world’s hardest hit countries, despite imposing a strict lockdown back in March. It has logged 1.23 million cases of the disease and 33,136 deaths.

Regulators have yet to approve a vaccine for COVID-19 but large global trials are well underway and early results are expected in November and December. Argentina is helping to produce the AstraZeneca-Oxford vaccine for Latin America.

Source: Mercopress

(Visited 146 times, 1 visits today)

About Gateway to South America

Established in 2006, Gateway to South America began as a single office in Buenos Aires. Since then, it has grown into a vibrant regional network, providing professional real estate marketing services to clients in Argentina, Brazil, Chile, Paraguay, Peru, and Uruguay. If you enjoy reading our news site, please share it on your social media!

Want an edge on investing in Latin America? Get our Investment News first: Join 39,400 subscribers without cost to our English, Spanish or Portuguese posts for the latest real estate news in LATAM useful for new and experienced investors. Please note, this subscription is for Investment News only, not properties for sale.

Post available in: English

Comments are disabled
Real Estate and Investment News from South America
Visit us on LinkedInVisit us on FacebookVisit us on TwitterVisit us on Pinterest